Lofexidine for Opiate Withdrawal - 1

NCT00032942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Lofexidine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]